市場調查報告書
商品編碼
1291348
基因治療市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球基因治療市場規模達到44億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到109億美元,在2023-2028年期間呈現15.39%的成長率(CAGR)。遺傳性疾病和獲得性疾病的發病率越來越高;醫院、診所和療養院的建設越來越多;以及新的基因療法的普及,為鴉片類藥物提供了更安全、無成癮性的替代品,這些都是推動市場的一些關鍵因素。
慢性病的發生率上升促進了市場成長
各種慢性病在群眾中的發病率越來越高,這是推動基因治療市場成長的關鍵因素之一。除此之外,由於採用不健康的生活方式,各種慢性病的發生,如心血管併發症、糖尿病、甲狀腺炎和肥胖症,也促進了市場的成長。此外,大眾中癌症病例的增加,以及對有效的腫瘤治療需求的成長,正在提供一個有利的市場前景。此外,由於過度吸煙的習慣,慢性肺部疾病的發生率越來越高,這也促進了基因治療市場的成長。
報告中涵蓋了競爭分析,如市場結構、主要參與者的市場佔有率、參與者定位、頂尖的製勝戰略、競爭儀表板和公司評估象限。此外,還提供了所有主要公司的詳細簡介。由於存在大量的全球和區域參與者,基因治療市場的結構是適度分散的。由於需要高額的資本投資、嚴格的政府政策,市場上新進入者的數量是適中的,而且產品差異化率很低。
什麼是基因治療?
基因治療是一種通過修改變異基因的表達或改變活細胞的生物特性來預防疾病進展的技術,用於治療。它包括不同的產品,如病毒載體、細菌載體、質粒脫氧核糖核酸(DNA)、人類基因編輯技術和病人衍生的細胞基因治療。它涉及將一個健康的基因引入個人的基因組,以修復促使遺傳疾病的突變。它包括各種療法,如體外、體內和原位基因療法。基因治療的功能是通過基因抑制、基因增強,並最終殺死致病細胞。它可以治愈某些藥物無法預防的疾病,並有可能永久地擺脫疾病症狀。它還能提高身體對抗各種疾病的能力,如癌症、糖尿病、血友病、囊性纖維化、心臟病和獲得性免疫缺陷症候群(AIDS)。此外,由於基因療法不像其他藥物那樣需要多次用藥,其需求在世界各地不斷增加。
冠狀病毒的爆發嚴重擾亂了基因治療市場,影響了各生物製藥公司的業績。一些基因治療公司由於其複雜的製造和交付系統以及籌資模式,面臨著大量的複雜問題。治療的製造和交付、研究和臨床開發以及商業運作受到大流行病的負面影響,這促使了基因治療市場成長的中斷。此外,支持基因治療產品的製造和開發的供應鏈需要受控和複雜的環境。供應鏈受到了封鎖和對通過道路移動的限制的嚴重影響。此外,有幾家公司報告說,由於COVID-19的爆發,經營出現了延誤或完全停止。
目前,對基因治療的需求不斷成長,因為它能有效地治愈各種危急和威脅生命的疾病,是積極影響市場的主要因素之一。除此之外,遺傳性疾病和後天性疾病在大眾中的流行率上升,也推動了市場的成長。此外,世界各地越來越多的醫院、診所和療養院的建設,為病人提供高品質的醫療保健服務,也促進了市場的成長。除此之外,新的基因療法的普及,為治療廣泛的慢性疼痛疾病,如下背痛和罕見的神經性疼痛疾病,提供了一個更安全和無成癮性的替代品,並創造有利的市場前景。
The global gene therapy market size reached US$ 4.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 15.39% during 2023-2028. The growing prevalence of inherited diseases and acquired disorders; increasing construction of hospitals, clinics, and nursing homes; and rising popularity of new gene therapy that offers a safer, non-addictive alternative to opioids represent some of the key factors driving the market.
Rising Occurrence of Chronic Diseases Augmenting Market Growth
The increasing prevalence of various chronic diseases among the masses represents one of the key factors propelling the growth of the gene therapy market. Besides this, the occurrence of various chronic diseases, such as cardiovascular complications, diabetes, thyroiditis, and obesity, due to the adoption of unhealthy lifestyle patterns is contributing to the growth of the market. Moreover, rising cases of cancer among the masses, along with the growing demand for effective oncology treatment, is offering a favorable market outlook. Furthermore, the increasing occurrence of chronic lung diseases due to excessive smoking habits is bolstering the growth of the gene therapy market.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The structure of the gene therapy market is moderately fragmented due to the presence of a large number of global and regional players. The volume of new entrants in the market is moderate due to the requirement for high capital investments, stringent government policies, and the rate of product differentiation is low.
What is Gene Therapy?
Gene therapy is a technique for preventing disease progression by modifying the expression of mutated genes or altering the biological properties of living cells for therapeutic use. It comprises different products, such as viral vectors, bacterial vectors, plasmid deoxyribonucleic acid (DNA), human gene-editing technology, and patient-derived cellular gene therapy. It involves the introduction of a healthy gene into the genome of an individual to repair a mutation that is causing a genetic disorder. It consists of various therapies, such as ex vivo, in vivo, and in situ gene therapy. Gene therapy functions via gene inhibition, gene augmentation, and ultimately killing the disease-causing cells. It can cure certain diseases which no medications can prevent and has the potential to get rid of disease symptoms permanently. It also improves the ability of the body to fight against a wide variety of diseases, such as cancer, diabetes, hemophilia, cystic fibrosis, heart disease, and acquired immunodeficiency syndrome (AIDS). Furthermore, as gene therapy does not require multiple doses like other medications, its demand is increasing around the world.
The outbreak of coronavirus severely disrupted the gene therapy market and affected the performance of various biopharmaceutical companies. Some gene therapy companies faced an immense number of complications due to their complicated manufacturing and delivery systems and funding models. The manufacture and delivery of treatment, research and clinical development, and commercial operations were negatively impacted by the pandemic, which resulted in a disruption in the growth of the gene therapy market. In addition, the supply chains that support the manufacturing and development of gene therapy products require controlled and complex settings. The supply chain was severely impacted by lockdowns and restrictions imposed on movement via roads. Furthermore, several companies reported delays or complete halts in operations due to the outbreak of COVID-19.
At present, the growing demand for gene therapy, as it is effective in curing various critical and life-threatening diseases, represents one of the primary factors influencing the market positively. Besides this, the rising prevalence of inherited diseases and acquired disorders among the masses is propelling the growth of the market. In addition, the increasing construction of hospitals, clinics, and nursing homes around the world to provide quality healthcare services to patients is contributing to the growth of the market. Apart from this, the rising popularity of new gene therapy that offers a safer and non-addictive alternative to opioids in treating a broad range of chronic pain conditions, such as lower back pain and rare neuropathic pain disorders, is offering a favorable market outlook.
IMARC Group provides an analysis of the key trends in each sub-segment of the global gene therapy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on gene type, vector type, delivery method and application.
Antigen
Cytokine
Tumor Suppressor
Suicide Gene
Deficiency
Growth Factors
Receptors
Others
The report has provided a detailed breakup and analysis of the gene therapy market based on the gene type. This includes antigen, cytokine, tumor suppressor, suicide gene, deficiency, growth factors, receptors, and others.
Viral Vector
Adenoviruses
Lentiviruses
Retroviruses
Adeno-Associated Virus
Herpes Simplex Virus
Poxvirus
Vaccinia Virus
Others
Non-Viral Techniques
Naked and Plasmid Vectors
Gene Gun
Electroporation
Lipofection
Others
A detailed breakup and analysis of the gene therapy market based on the vector type has also been provided in the report. This includes viral vector (adenoviruses, lentiviruses, retroviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others) and non-viral techniques (naked and plasmid vectors, gene gun, electroporation, lipofection, and others). According to the report, viral vector (adenoviruses, lentiviruses, retroviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others) accounted for the largest market share as it is highly efficient in mitigating the impacts of infectious diseases and viruses. In addition, the rising utilization of viral vectors as they are easy to handle and modify is propelling the growth of the respective segment.
In-Vivo Gene Therapy
Ex-Vivo Gene Therapy
A detailed breakup and analysis of the gene therapy market based on the delivery method has also been provided in the report. This includes in-vivo gene therapy and ex-vivo gene therapy.
Oncological Disorders
Rare Diseases
Cardiovascular Diseases
Neurological Disorders
Infectious Disease
Others
A detailed breakup and analysis of the gene therapy market based on the application has also been provided in the report. This includes oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and others. According to the report, oncological disorders accounted for the largest market share due to increasing occurrence of cancer among the masses. Apart from this, the rising employment of gene therapy in cancer treatment as it provides remarkable efficacy is bolstering the growth of the market.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for gene therapy. Some of the factors driving the North America gene therapy market included the rising awareness about the benefits of gene therapy in treating various chronic diseases and the increasing expenditure in research and development (R&D) activities to develop effective gene therapies is propelling the market growth. In addition, the growing construction of various healthcare facilities to provide quality treatment to patients is propelling the growth of the market.
Abeona Therapeutics Inc.
Adaptimmune Therapeutics plc
Adverum Biotechnologies Inc.
Amgen Inc.
Astellas Pharma Inc.
Biogen Inc.
Bluebird Bio Inc.
Mustang Bio Inc. (Fortress Biotech Inc.)
Novartis AG
Orchard Therapeutics plc
UniQure N.V.
Voyager Therapeutics Inc.
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What was the size of the global gene therapy market in 2022?
2. What is the expected growth rate of the global gene therapy market during 2023-2028?
3. What are the key factors driving the global gene therapy market?
4. What has been the impact of COVID-19 on the global gene therapy market?
5. What is the breakup of the global gene therapy market based on the vector type?
6. What is the breakup of the global gene therapy market based on the application?
7. What are the key regions in the global gene therapy market?
8. Who are the key players/companies in the global gene therapy market?